CONTINEUM THERAPEUTICS INC-A (CTNM) Institutional Shareholders

CONTINEUM THERAPEUTICS INC-A (CTNM) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $461.26M in CTNM holdings during the latest filing period.

Suvretta Capital Management, Llc is currently the largest disclosed institutional shareholder of CTNM tracked by InsiderSet, reporting ownership valued at approximately $46.57M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $38.44M, representing an estimated loss of -17.45% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 57% of the total disclosed CTNM value among the investors covered in this analysis. Major shareholders include Suvretta Capital Management, Llc, Janus Henderson Group Plc, Blackrock, Inc., and several other long-term asset managers with concentrated positions in CONTINEUM THERAPEUTICS INC-A (CTNM).

This page ranks the largest institutional CTNM shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

102

Total Reported Value

$461.26M

Largest Holder

Suvretta Capital Management, Llc

Largest Position

$46.57M

Insider Transactions (90d)

12

Latest Filing Quarter

Q2 2026

New Institutional Positions

125

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Suvretta Capital Management, Llc0.98%2,841,334$46,569,464$38,443,249-$8,126,215-17.45%
Janus Henderson Group Plc0.02%2,734,836$35,593,891$37,002,331+$1,408,440+3.96%
Blackrock, Inc.0.00%2,064,345$33,834,614$27,930,588-$5,904,026-17.45%
Johnson & Johnson4.06%1,979,173$32,438,645$26,778,211-$5,660,434-17.45%
Balyasny Asset Management L.P.0.05%1,522,793$24,958,577$20,603,389-$4,355,188-17.45%
Vanguard Capital Management Llc0.00%1,321,356$21,657,025$17,877,947-$3,779,078-17.45%
Perceptive Advisors Llc0.32%1,255,592$20,579,153$16,988,160-$3,590,993-17.45%
Fmr Llc0.00%1,040,130$17,047,731$14,072,959-$2,974,772-17.45%
Millennium Management Llc0.01%931,709$15,270,711$12,606,023-$2,664,688-17.45%
Great Point Partners Llc3.56%921,481$15,103,074$12,467,638-$2,635,436-17.45%
Longaeva Partners L.P.0.38%812,757$13,321,087$10,996,602-$2,324,485-17.45%
Ikarian Capital, Llc2.17%807,874$13,241,056$10,930,535-$2,310,521-17.45%
Sectoral Asset Management Inc8.32%727,587$11,925,151$9,844,252-$2,080,899-17.45%
Geode Capital Management, Llc0.00%693,188$11,364,044$9,378,834-$1,985,210-17.47%
Hhlr Advisors, Ltd.1.32%669,337$10,970,433$9,056,130-$1,914,303-17.45%
Red Tree Management, Llc7.10%638,158$10,459,410$8,634,278-$1,825,132-17.45%
Versant Venture Management, Llc5.47%542,628$8,893,673$7,341,757-$1,551,916-17.45%
Goldman Sachs Group Inc0.00%497,255$8,150,009$6,727,860-$1,422,149-17.45%
Boxer Capital Management, Llc0.61%494,000$8,096,660$6,683,820-$1,412,840-17.45%
State Street Corp0.00%425,902$6,980,534$5,762,454-$1,218,080-17.45%
Citadel Advisors Llc0.00%396,354$6,496,242$5,362,670-$1,133,572-17.45%
Adage Capital Partners Gp, L.L.C.0.01%328,000$5,375,920$4,437,840-$938,080-17.45%
Silverarc Capital Management, Llc0.54%296,135$4,853,653$4,006,707-$846,946-17.45%
Adar1 Capital Management, Llc0.21%278,961$4,572,171$3,774,342-$797,829-17.45%
Northern Trust Corp0.00%277,804$4,553,208$3,758,688-$794,520-17.45%
Squadron Capital Management Llc1.46%260,000$4,261,400$3,517,800-$743,600-17.45%
Boothbay Fund Management, Llc0.07%222,329$3,643,972$3,008,111-$635,861-17.45%
Charles Schwab Investment Management Inc0.00%214,082$3,508,804$2,896,529-$612,275-17.45%
Ishara Investments Lp2.47%205,000$3,359,950$2,773,650-$586,300-17.45%
Sphera Funds Management Ltd.0.43%183,475$3,007,155$2,482,417-$524,738-17.45%
Qube Research & Technologies Ltd0.00%182,413$2,989,749$2,468,048-$521,701-17.45%
Vanguard Portfolio Management Llc0.00%180,302$2,955,150$2,439,486-$515,664-17.45%
Dimensional Fund Advisors Lp0.00%178,673$2,925,440$2,417,446-$507,994-17.36%
Vanguard Fiduciary Trust Co0.00%177,281$2,905,636$2,398,612-$507,024-17.45%
Wellington Management Group Llp0.00%150,797$2,471,563$2,040,283-$431,280-17.45%
Casdin Capital, Llc0.12%148,333$2,431,178$2,006,945-$424,233-17.45%
Eversept Partners, Lp0.13%148,017$2,425,999$2,002,670-$423,329-17.45%
Ubs Group Ag0.00%130,642$2,141,223$1,767,586-$373,637-17.45%
Diadema Partners Lp0.69%119,733$1,962,424$1,619,987-$342,437-17.45%
Marshall Wace, Llp0.00%118,058$1,934,971$1,597,325-$337,646-17.45%
Trexquant Investment Lp0.01%88,479$1,450,171$1,197,121-$253,050-17.45%
Verdad Advisers, Lp1.27%81,014$1,327,819$1,096,119-$231,700-17.45%
Bnp Paribas Financial Markets0.00%78,920$1,293,499$1,067,788-$225,711-17.45%
Susquehanna International Group, Llp0.00%75,559$1,238,412$1,022,313-$216,099-17.45%
Schonfeld Strategic Advisors Llc0.01%69,441$1,138,137$939,537-$198,600-17.45%
Renaissance Technologies LLCJim Simons0.00%67,300$1,103,047$910,569-$192,478-17.45%
Bank Of New York Mellon Corp0.00%65,604$1,075,249$887,622-$187,627-17.45%
Acuta Capital Partners, Llc0.72%63,095$1,034,127$853,675-$180,452-17.45%
Seven Fleet Capital Management Lp0.16%60,541$992,267$819,120-$173,147-17.45%
Ameriprise Financial Inc0.00%60,253$987,546$815,223-$172,323-17.45%
Showing 50 of 102

Frequently asked questions about CTNM

  • Who owns the most CTNM stock?

    The largest holders of CTNM are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for CONTINEUM THERAPEUTICS INC-A (CTNM).

  • Is CTNM widely held by superinvestors?

    Many widely followed stocks like CTNM appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CTNM is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.